Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001159036-26-000149

Director sold 5,000 shares at an average $96.43 ($482,147)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Posard Matthew L. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-11-18 Sale : show line 1 in the form 10b5-1 −3,400 $96.17 $326,988 50,209 D
2026-11-18 Sale : show line 2 in the form 10b5-1 −1,600 $96.97 $155,158 48,609 D
Open-market sales · 5,000 sh · avg $96.43 · $482,147
Loading xslF345X06/wk-form4_1795045684.xml…